One of the largest pharma companies in the world has made a big move in cannabis
As the cannabis industry advances, we’ll likely see more and more big pharma companies ink deals with cannabis firms
Thursday, September 12, 2019
A subsidiary of NYSE-traded giant Teva Pharmaceuticals has signed a deal with medical cannabis company Canndoc to distribute its GMP products to pharma customers, including hospitals, health maintenance organizations (HMOs) and all pharmacies in Israel. It should be noted that, almost by any measure, from market cap to revenue, Teva is one of the largest pharma companies in the world, and considered to be the biggest generic drug manufacturer in the globe. Needless to say, this is a big deal. Beyond specific deals, a few big pharma companies have registered cannabinoid-related clinical trials in the U.S. and Canada.